In vitro effects of doxorubicin and mitomycin C on human tenon’s capsule fibroblasts

Ophthalmic Research

Volumn 29, Issue 2, 1997, Pages 91-102

  Saika, Shizuya ^a   Ooshima, Akira ^a   Yamanaka, Osama ^a   Kimura, Michio ^b   Okada, Yuka ^a   Tonoe, Osamu ^a   Tanaka, Sai Ichi ^a   Ohnishi, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Department of Anatomy   (Japan)

Author keywords

Collagen; Doxorubicin; Laminin; Mitomycin; Tenon's capsule fibroblast

Indexed keywords

COLLAGEN TYPE 1; DOXORUBICIN; LAMININ; MITOMYCIN C; PROCOLLAGEN; VITRONECTIN RECEPTOR;

ADULT; ARTICLE; CELL LYSATE; CELL PROLIFERATION; CELL SECRETION; CELL ULTRASTRUCTURE; CELL VIABILITY; FEMALE; FIBROBLAST; FIBROSIS; FILTERING OPERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LYSOSOME; MALE; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0030898712     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000268002     Document Type: Article

References (45)

1. Addicks EM, Quigley HA, Green WR, Robin AL: Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983:101:795-798.
2. Desjardins DC, Parrish HRK, Fol-berg R, Nevarez J, Heuer DK, Gres-scl MG: Wound healing after filtering surgery in owl monkeys. Arch Ophthalmol 1986; 104:1835-1839.
3. Jampel HD, McGuigan IJB, Dun-kclberger GR, L'Hernault NL, Quigley HA: Cellular proliferation after experimental glaucoma Alteration surgery. Arch Ophthalmol 1988: 106:89-94.
4. Jampel HD: Effect of brief exposure to mitomycin C on viability and proliferation of human Tenon's capsule fibroblasts. Ophthalmology 1992:99:1471-1476.
5. Lee DA, Shapourifar-Tehrani S, Ki-tada S: The effect of 5-fiuorcuracil and cytarabine on human fibroblasts from Tenon’s capsule. Invest Ophthalmol Vis Sci 1990:31:1848-1855.
6. Lee DA, Lee TC, Cortes AE. Kitada S: Effects of mithramycin. mitomycin. daunorubicin. and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990:31: 2136-2144.
7. Yamamoto T, Varani J, Soong HK, Lichter PR: Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990:97:1204-1210.
8. Grcssel MG, Parrish RK II, Folberg R: 5-Fluorouracil and glaucoma filtering surgery. I. An animal model. Ophthalmology 1984:91:378-383.
9. Heuer DK, Gressel MG, Parrish RK II, Folberg R, Dillberger JE, Altman NH: Topical fluorouracil. II. Postoperative administration in an animal model of glaucoma filtering surgery. Arch Ophthalmol 1986:104: 132-136.
10. Pasquale LR, Thibault D, Dorman-I’casc ML, Quiglcy HA, Jampcl HD: Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. Ophthalmology 1992:99:14-18.
11. Heuer DK, Parrish RK II, Gressel MG, Hodapp E, Palmberg PF, Anderson DR: 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study. Ophthalmology 1986:93: 1537-1546.
12. Kitazawa Y, Kawase K, Matsushita H, Minobc M: Trabeculectomy with mitomycin: A comparative study with fluorouracil. Arch Ophthalmol 1991:109:1693-1698.
13. Handa JT, Murad S, Jaffe GJ: Minoxidil inhibits ocular cell proliferation and lysyl hydroxylase activity. Invest Ophthalmol Vis Sei 1993:34: 567-575.
14. Kivirikko KI, Myllyla R, Pihlajan-icmi T: Protein hydroxylation: Prolyl 4-hydroxylasc. an enzyme with four cosubstrales and a multifunctional subunit. FASEB .J 1989:3: 1609-1617.
15. Pihlajaniemi T, Myllyla R, Kivirikko KI: Prolyl 4-hydroxylase and its role in collagen synthesis. J I lepatol 1991:13(suppl 3):S2-S7.
16. Helaakoski T, Vouri K, Myllyla R, Kivirikko KI, Pihlajaniemi T: Molecular cloning of the a-subunit of human prolyl 4-hvdroxylasc: The complete cDNA-derivcd amino acid sequence and evidence for alterna-tivc splicing of RNA transcripts. Proc Natl Acad Sei USA 1989:86: 4392-4396.
17. Koivu J, Myllyla R, Helaakoski T, Pihlajaniemi T, Tasanen K, Kivirikko KI: A single polypeptide acts both as the ß-subunit of prolyl 4-hydroxylasc and as a protein disul-fide-isomerase. J Biol Chcm 1987; 262:6447-6449.
18. Pihlajaniemi T, Helaakoski T, Tasanen K, Myllyla R, Huhtala ML, Koivu J, Kivirikko KI: Molecular cloning of the ß-subunit of human prolyl 4-hydroxylasc: This subunit and protein disulfide isomcrase are products of the same gene. EMBO J 1987;6:643-649.
19. Cheng SY, Gong QH, Parkinson C, Robinson EA, Appella E, Mcrlino GI, Pasten I: The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum. J Biol Chem 1987;262:11221-11227.
20. Takeuchi T, Kivirikko KI, Prockop DJ: Increased prolocollagen hydroxylase activity in the liver of rats with hepatic fibrosis. Biochem Biophys ResCommun 1967;28:940-944.
21. Mussini E, Hutton JJ Jr, Uden-friend S: Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science 1967;157:927-929.
22. Ooshima A, Fuller GC, Cardinalc GJ, Spcctor S. Udenfriend S: Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci USA 1974:71: 3019-3023.
23. Ooshima A, Fuller GC, Cardinale GJ, Spector S. Udenfriend S: Collagen biosynthesis in blood vessels of brain and other tissues of the hypertensive rat. Science 1975:190:898-900.
24. Saika S, Ooshima A, Yamanaka O, Okada Y, Ohnishi Y, Kimura M: Immunolocalization of prolyl 4-hydroxylasc in cultured Tenon's capsule fibroblasts of humans. Gracfc's Arch Clin Exp Ophthalmol 1995; 234:251-257.
25. Tonoe O, Yamanaka O, Okada Y, Kobata S, Saika S: Collagen biosynthesis and cellular proliferation after filtering surgery in rabbits (in Japanese). Folia Ophthalmol Jpn 1995; 46:242-245.
26. Tonoe O, Yamanaka O, Okada Y, Kobata S, Saika S: Immunolocalization of the bcta-subunit of prolyl 4-hydroxylase in rat limbal tissue, cultured subconjunctival fibroblasts and rabbit scleral wound tissue after filtering surgery. Invest Ophthalmol Vis Sci 1995;36(supp1):S92.
27. Sasaki T, Majamaa K, Uitto J: Reduction of collagen production in keloid fibroblast cultures by ethyl-3.4-dihydroxybcn/.oate. J Biol Chem 1987:262:9397-9403.
28. Saika S, Oohsima A, Yamanaka O, Tanaka S, Okada Y, Hashizume N, Ohnishi Y: Effect of a prolyl hydroxylase inhibitor on rabbit ocular fibroblasts. Ophthalmic Res 1995:27: 335-346.
29. Ishimaru T, Kanamaru T, Ohta K, Okazaki H: Fibrostatins, new inhibitors of prolyl hydroxylase. I. Toxon-omv. isolations and characterization. J Antibiot 1987:40:1231-1238.
30. Ishimaru T, Kanamaru T, Takaha-shi T, Okazaki H: Inhibition of prolyl hydroxylase activity and collagen biosynthesis by fibrostatin C. a novel inhibitor produced by Slrepio-ntyces calenulae subsp. griseospora No. 23924. J Antibiot 1988:41: 1668-1674.
31. Kawaguchi Y, Harigai M, Kitani A, Suzuki K, Kawakanti M, Ishizu-ka T, Hara M, Kawagoe M, Nakamura H: Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro. An approach to the treatment of systemic sclerosis. J Rheumatol 1992:19:1710-1715.
32. Ohta K, Kasahara F, Ishimaru T, Wada Y, Kanamaru T, Okazaki H: Structures of fibrostatins, new inhibitors of prolyl hydroxylase. J Antibiot 1987.40:1239-1248.
33. Saika S, Ooshima A, Yamanaka O, Okada Y, Tanaka S, Ohnishi Y: Effect of fibrostatin C. an inhibitor of prolyl 4-hydroxylasc. on collagen secretion by human Tenon's capsule fibroblasts in vitro. Gracfc's Arch Clin Exp Ophthalmol 1996; 234:214-222.
34. Murad S, Pinnell SR: Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J Biol Chem 1987:262:1 1973-11978.
35. Saika S, Ooshima A, Hasizume N, Yamanaka O, Okada Y, Tanaka S, Kobata S: Effect of a lysyl hydroxylase inhibitor, minoxidil, on ultrastructure and behavior of cultured rabbit subconjunctival fibroblasts. Gracfc's Arch Clin Exp Ophthalmol 1995;233:347-353.
36. Ycowcll HN. Ha V. Walker LC. Murad S. Pinnell SR: Characterization of a partial cDNA for lysyl hydroxylase from human skin fibroblasts: Lysyl hydroxylase mRNAs are regulated differently by minoxidil derivatives and hydralazine. J Invest Dermatol 1992:99:864-986.
37. Low SQ, Kitada S, Lee DA: Intcrfcr-on-y inhibits collagen synthesis by human Tenon's capsule fibroblasts in vitro. Invest Ophthalmol Vis Sci 1991:32:2964-2969.
38. Nguyen KD, Hoang AT, Lee DA: Transcriptional control of human Tenon's capsule fibroblast collagen synthesis in vitro by gamma-inter-fcron. Invest Ophthalmol Vis Sci 1994:35:3064-3070.
39. Sasaki T, Holeyfield KC, Uitto J: Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures: Relevance to impaired wound healing. J Clin Invest 1987:80:1735-1741.
40. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J: Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. .1 Bone Miner Res 1993:8:127-132.
41. Melkko J, Niemi S, Risteli L, Risteli J : Radioimmunoassay of thecarbox-yterminal propeptide of human type I procollagcn. Clin Chcm 1990:35: 1328-1332.
42. Parfitt AM, Simon LS, Villanueva AR, Krane SM: Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone: Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987:2:427-436.
43. −collagen. Proc Natl Acad Sci USA 1980:77:4746-4750.
44. Berg RA, Schwartz ML, Rome LH, Crystal RG: Lysosomal function in the degradation of defective collagen in cultured lung fibroblasts. Biochemistry' 1984:23:2134-2138.
45. Berg RA, Steinmann B, Rennard SI, Crystal RG: Ascorbate deficiency results in decreased collagen production: Undcrhydroxyiation of proline leads to increased intracellular degradation. Arch Biochem Biophys 1983;226:681-686.